Korea prepares new drugs to treat leukemia
According to the Korean news network, a country's pharmaceutical company first developed a new drug capable of treating leukemia in Asia.
According to the Korean news network, a country's pharmaceutical company first developed a new drug capable of treating leukemia in Asia.
>>>Announcing methods to reverse leukemia
The Korean Food and Drug Administration (KFDA) said the government has allowed the production and sale of a capsule called Shupect, produced by the pharmaceutical company Ilyang.
Shupect is the 18th drug developed in Korea and functions to treat chronic granulomatous leukemia (CML) and is applicable to patients with Gleevec greasy, leukemia medications present.
Ilyang Pharmaceutical Company said that thanks to the development of this new drug, Korea could save the cost of paying foreign drug rights more than 52.1 million USD / year.
Along with that, the company will raise the competitiveness in the market for drugs to treat leukemia in the world with a value of more than 5 billion USD.
- The only girl in the world who has 2 leukemia
- Leukemia is caused by genes
- How dangerous is diphtheria?
- Hope for leukemia patients
- Detection of risk of leukemia due to low dose radiation
- Korea: Drugs to treat bird flu from kimchi!
- Green tea inhibits anti-cancer drugs
- Things to know about blood cancer
- The most common cancer in children turns out to be preventable
- Three new drugs that treat rheumatoid arthritis effectively
Italian teenager will become the first saint of the millennium New drugs treat leukemia rarely in humans X-rays and leukemia Australian scientists have released a drug that can cure cancer The most common cancer in children turns out to be preventable Zebra fish help cure blood cancer Successfully modulate drugs that can cure blood cancer Why can cancer get caught?